Lantheus Holdings Inc (LNTH)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | HEALTH CARE SUPPLIES |
| SIC: | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| CEO: | Mary A. Heino |
| Employees: | 700 |
| Web site: | lantheus.com |
|
331 TREBLE COVE ROAD, NORTH BILLERICA, MA, 01862
978 671-8001
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates disease burden of prostate cancer by quantifying the hotspots on bone scans.
Please log in first to see chart